Reduction of the false-positive rate in newborn screening by implementation of MS/MS-based second-tier tests: the Mayo Clinic experience (2004–2007)
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
The continued expansion of newborn screening programmes to include additional conditions increases the responsibility of newborn screening laboratories to provide testing with the highest sensitivity and specificity to allow for identification of affected patients while minimizing the false-positive rate. Some assays and analytes are particularly problematic. Over recent years, our laboratory tried to improve this situation by developing second-tier tests to reduce false-positive results in the screening for congenital adrenal hyperplasia (CAH), tyrosinaemia type I, methylmalonic acidaemias, homocystinuria, and maple syrup urine disease (MSUD). Beginning in 2004, this approach was applied to Mayo's newborn screening programme and resulted in a false-positive rate of 0.09%, a positive predictive value of 41%, and a positive detection rate of 1 affected case in 1672 babies screened.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and both heel stick blood samples (266) and urine samples (267,268) can also be analyzed by mass spectrometric methods.”
From Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management (2022) · cites this paper as [267]
In the citing paper
“This strategy was used in actual practice as the second-tier screen in Minnesota for 3 years (204,000 births) and improved the positive predictive value of the CAH screen (82), but subsequent reports from the same center suggested that this approach was inferior to testing a second sample by routine immunoassay (67,68).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [82]
Citations
Cites
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
The metabolic and molecular bases of inherited disease
Chen, Y.-T. (2001) · Medical Entomology and Zoology · Cited by 6,928
Transplantation of Umbilical-Cord Blood in Babies with Infantile Krabbe's Disease
Escolar, M. L., Poe, M. D., Provenzale, J. M., Richards, K. C., Allison, J., Wood, S., Wenger, D. A., Pietryga, D., Wall, D., Champagne, M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042604 · Cited by 709
Use of Tandem Mass Spectrometry for Multianalyte Screening of Dried Blood Specimens from Newborns
Chace, D. H., Kalas, T. A., & Naylor, E. W. (2003) · Clinical Chemistry · doi:10.1373/clinchem.2003.022178 · Cited by 621
Development of population-based newborn screening for severe combined immunodeficiency
Chan, K., & Puck, J. M. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.10.012 · Cited by 419
Waisbren, S. E. (2003) · JAMA · doi:10.1001/jama.290.19.2564 · Cited by 360
Direct Multiplex Assay of Lysosomal Enzymes in Dried Blood Spots for Newborn Screening
Li, Y., Scott, C. R., Chamoles, N. A., Ghavami, A., Pinto, B. M., Turecek, F., & Gelb, M. H. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.035907 · Cited by 332
Expanded Newborn Screening for Biochemical Disorders: The Effect of a False-Positive Result
Gurian, E. A., Kinnamon, D. D., Henry, J. J., & Waisbren, S. E. (2006) · Pediatrics · doi:10.1542/peds.2005-2294 · Cited by 223
Lacey, J. M., Minutti, C. Z., Magera, M. J., Tauscher, A. L., Casetta, B., McCann, M., Lymp, J., Hahn, S. H., Rinaldo, P., & Matern, D. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2003.027193 · Cited by 216 · cited 1×
“To avoid unnecessary recalls, we developed an assay using liquid chromatography–tandem mass spectrometry (LC-MS/ MS) that allows detection of 17-OHP, androstene- dione and cortisol simultaneously (Lacey et al 2004).”
MethodSelf-citationEnsenauer, R., Vockley, J., Willard, J.-M., Huey, J. C., Sass, J. O., Edland, S. D., Burton, B. K., Berry, S. A., Santer, R., Grünert, S., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/426318 · Cited by 167
Self-citation
Research works printed but not linked: 3
- Kirk K, 2007, Paper presented at 2007 Newborn Screening and Genetic Testing Symposium
- Matern D, 2005, Paper presented at 2005 Newborn Screening and Genetic Testing Symposium
- Saavedra‐Matiz C, 2007, Paper presented at 2007 Newborn Screening and Genetic Testing Symposium
Cited by
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468
Speiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234
Principles and applications of liquid chromatography-mass spectrometry in clinical biochemistry.
Pitt, J. J. (2009) · PubMed · Cited by 919
Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia
Baumgartner, M. R., Hörster, F., Dionisi-Vici, C., Haliloglu, G., Karall, D., Chapman, K. A., Huemer, M., Hochuli, M., Assoun, M., Ballhausen, D., et al. (2014) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-014-0130-8 · Cited by 705
Dried blood spot sampling in combination with LC‐MS/MS for quantitative analysis of small molecules
Li, W., & Tse, F. L. S. (2010) · Biomedical Chromatography · doi:10.1002/bmc.1367 · Cited by 599
Metadata
- Authors
- Matern, D., Tortorelli, S., Oglesbee, D., Gavrilov, D., & Rinaldo, P.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Matern, D.
- Venue
- Journal of Inherited Metabolic Disease
- Publisher
- Wiley
- Published
- 2007-07-23
- Volume
- 30
- Issue
- 4
- Pages
- 585-592
- ISSN
- 0141-8955 (ISSN-L)
- 1573-2665
- OpenAlex
- W1981566444
- Cited by
- 217
- References
- 30
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 7 · 2023: 13 · 2022: 14 · 2021: 24 · 2020: 15 · 2019: 9 · 2018: 9 · 2017: 9 · 2016: 6 · 2015: 10 · 2014: 13 · 2013: 9 · 2012: 10
- FWCI
- 8.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Inherited Metabolic Disease (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Keywords
- newborn screening, false positive rate, second-tier testing, tandem mass spectrometry, congenital adrenal hyperplasia, methylmalonic acidemia, homocystinuria, maple syrup urine disease, positive predictive value, inborn errors of metabolism
- MeSH terms
- Adrenal Hyperplasia, Congenital, False Positive Reactions, Homocystinuria, Humans, Infant, Newborn, Maple Syrup Urine Disease, Predictive Value of Tests, Sensitivity and Specificity, Mass Spectrometry, Time Factors, Vitamin B 12 Deficiency, Neonatal Screening, Tyrosinemias
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Reduction of the false-positive rate in newborn screening by implementation of MS/MS-based second-tier tests: the Mayo Clinic experience (2004–2007). https://app.cochat.ai/papers/10.1007/s10545-007-0691-y
- The paper
- Matern, D., Tortorelli, S., Oglesbee, D., Gavrilov, D., & Rinaldo, P. (2007). Reduction of the false-positive rate in newborn screening by implementation of MS/MS-based second-tier tests: the Mayo Clinic experience (2004–2007). Journal of Inherited Metabolic Disease. https://doi.org/10.1007/s10545-007-0691-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.